Monday, 28 September 2026Updated 10m ago
← Top stories
Expansion● Neutral for Indian equities

Lord’s Mark advances AI breast cancer screening towards clinical trials

1 source · first seen 16:30 25 Sept · updated 16:30 25 Sept

The brief

Written from 1 report · check the source before you trade
  • Lord’s Mark and C-MET are advancing AI breast cancer screening towards clinical trials
  • Progress in screening technology may benefit Indian healthcare and diagnostics companies

Tags on this story

Pick a tag to see all its stories
AI58 todayPharma and healthcare19 today

Linked by the tag Pharma and healthcare

61 stories this week
  1. 27 SeptFortis says independent audit will establish non-involvement in Singh brothers’ share transfersLegal · 2 sources · Supreme Court cleared the way for an independent forensic audit of the share transfers
  2. 27 SeptFortis confident of clean chit from audit in Singh brothers’ disputeLegal · 1 source · Fortis expects a clean chit from the audit in the Singh brothers’ dispute
  3. 25 SeptSupreme Court allows independent forensic audit of Fortis transactions in Daiichi disputeLegal · 6 sources · The Supreme Court declined to interfere with Delhi High Court orders allowing the audit
  4. 25 SeptRegulator mulls digital platform for drugmakers' test reportsPolicy · 1 source · India’s drug regulator is developing a digital platform for consumers to view batch-level quality-test reports
  5. 24 SeptMint Explainer | Why NHRC wants India’s drugs regulator to build a national digital registryPolicy · 1 source · NHRC wants the drugs regulator to build a national digital registry using QR codes and drug-tracking tools
All Pharma and healthcare stories →

Read the reports

1 report · earliest 16:30
Economic TimesLord’s Mark advances AI breast cancer screening towards clinical trials16:30